Drug Trial Radar · NCT01743729
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Last checked: Nov 20, 2026Latest source record: Jun 23, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
720
Actual
Start
Dec 7, 2012
Primary completion
Oct 1, 2013
Study completion Oct 1, 2013
Sponsor
- Lead sponsor
- ShireTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Dec 6, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate the safety and efficacy of lifitegrast ophthalmic solution compared to placebo in the treatment of dry eye.
Conditions
- Dry Eye Disease
Interventions
LifitegrastDrug
Lifitegrast Ophthalmic Solution 5.0%
PlaceboDrug
Placebo for Lifitegrast Ophthalmic Solution 5.0%
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Inferior Corneal Fluorescein Staining Score to Day 84Time frame: Baseline to Day 84
- Change From Baseline in Eye Dryness Score (Visual Analogue Scale) to Day 84Time frame: Baseline to Day 84
Locations
31 sites in 1 country. Site status is shown where the registry gives one.
OPUS-2 Investigational Site
Artesia, California
OPUS-2 Investigational Site
Hemet, California
OPUS-2 Investigational Site
Lancaster, California
OPUS-2 Investigational Site
Mission Hills, California
OPUS-2 Investigational Site
Montebello, California
OPUS-2 Investigational Site
Newport Beach, California
OPUS-2 Investigational Site
Petaluma, California
OPUS-2 Investigational SIte
Rancho Cordova, California
OPUS-2 Investigational Site
Danbury, Connecticut
OPUS-2 Investigational Site
Fort Myers, Florida
OPUS-2 Investigational Site
Hoffman Estates, Illinois
OPUS-2 Investigational Site
Indianapolis, Indiana
OPUS-2 Investigational Site
New Albany, Indiana
OPUS-2 Investigational Site
Lexington, Kentucky
OPUS-2 Investigational Site
Saint Paul, Minnesota
OPUS-2 Investigational Site
Chesterfield, Missouri
OPUS-2 Investigational Site
Des Peres, Missouri
OPUS-2 Investigational Site
Independence, Missouri
OPUS-2 Investigational Site
Kansas City, Missouri
OPUS-2 Investigational Site
Washington, Missouri
OPUS-2 Investigational Site
New York, New York
OPUS-2 Investigational Site
New York, New York
OPUS-2 Investigational Site
Wantagh, New York
OPUS-2 Investigational Site
Cleveland, Ohio
OPUS-2 Investigational Site
Philadelphia, Pennsylvania
OPUS-2 Investigational Site
Houston, Texas
OPUS-2 Investigational Site
Houston, Texas
OPUS-2 Investigational Site
League City, Texas
OPUS-2 Investigational Site
San Antonio, Texas
OPUS-2 Investigational Site
San Antonio, Texas
OPUS-2 Investigational Site
Norfolk, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.